Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ribosepharm

ribosepharm
1983 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
4 FINANCING ROUNDS
Description

Wholesaler and distributor of medicines for cancer treatment. The company specializes in medicines for colorectal tumors and hematological diseases.

Formerly Known As
ribopharm
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Distributors (Healthcare)
Parent Company
Primary Office
  • Lochhamer Schlag 17
  • 82166 Gräfelfing
  • Germany

+49 089 000000

ribosepharm Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ribosepharm‘s full profile, request access.

Request full access to PitchBook

ribosepharm Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore ribosepharm‘s full profile, request access.

Request full access to PitchBook

ribosepharm Executive Team (1)

Name Title Board
Seat
Contact
Info
Jens Wartmannn Chief Executive Officer